Skip to content
Menu

OnKure Therapeutics, Inc. OKUR

Full chart Compare
Set alert

Price alert · OKUR

All alert types
2.63 USD -0.38 (-12.62%)

Regular-session close

2.63 0.00 0.00%

After hours · Nov 13, 4:00 PM ET

2.60 Day range 3.08
2.01 52-week range 5.38
YTD
-9.31%
1 year
-16.24%

Fundamental scorecard

4 of 25 checks passed on OKUR’s reported financials

Value: 1/5ValueGrowth: 0/5GrowthProfitability: 0/5ProfitabilityFinancial health: 3/5HealthDividend: 0/5Dividend

4of 25 checks passed

  • Value 1 of 5
  • Growth 0 of 5
  • Profitability 0 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Value 1 of 5

  • Failed:P/E below its own 5-year median No profit over the last 12 months, so no P/E.
  • Failed:P/E under 20 No profit over the last 12 months, so no P/E.
  • Failed:Price to sales below its own 5-year median Not enough data to decide.
  • Passed:Price to book below its own 5-year median Price to book 0.7 against a 5-year median of 0.9.
  • Failed:Free cash flow yield above 4% Free cash flow of -47.9M is -44.2% of the market value.

Growth 0 of 5

  • No data:Revenue grew over the last year Not enough data to decide.
  • No data:Revenue grew more than 5% a year over five years Not enough data to decide.
  • Failed:Earnings per share grew over the last year EPS -2.77 against 93.07 in the 12 months before.
  • Failed:Earnings per share grew more than 5% a year over five years EPS -96.00 in FY 2020, -4.40 in FY 2025.
  • Failed:Analysts expect higher earnings per share over the next year The average forward estimate is -3975.0% on the last 12 months.

Profitability 0 of 5

  • Failed:Profitable over the last year Net income of -61.9M over the last 12 months.
  • Failed:Profitable in each of the last five fiscal years A profit in 0 of the last 5 fiscal years.
  • Failed:Return on equity above 15% Return on equity of -55.2%.
  • No data:Net margin above its 5-year average Not enough data to decide.
  • Failed:Free cash flow is at least 80% of net income No profit over the last 12 months to compare with.

Financial health 3 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 166M against short-term liabilities of 8.79M.
  • Passed:Short-term assets cover long-term liabilities Short-term assets of 166M against long-term liabilities of 551K.
  • Passed:Net debt under 40% of equity More cash than debt: 163M of cash against 790K of debt.
  • Failed:Operating cash flow covers at least 20% of debt Operating cash flow of -47.9M is -6061.5% of debt.
  • Failed:Operating profit covers interest at least 3 times Operating profit is -10307.7 times the interest expense.

Dividend 0 of 5

  • Failed:Pays a dividend No dividend paid.
  • Failed:Yield above 1.5% No dividend paid.
  • Failed:Pays out under 75% of profit No dividend paid.
  • Failed:Covered by free cash flow No dividend paid.
  • Failed:Not cut in the last five fiscal years No dividend paid.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

P/E against peers

Price over the last twelve months of earnings, OKUR and similar companies

OKUR has no P/E (no profit over the last year); its peers' median is 8.5.

Peers’ median 8.5. A bar with a notched end runs past the scale. Peers are companies in a similar business; a P/E alone does not say whether a stock is cheap.

Financial position

What OKUR owns and owes, as of Sep 30, 2026

Short term and long term

Balance sheet · 167M of assets

Debt, equity and cash by year

Now: 163M more cash than debt

  • Equity
  • Debt
  • Cash

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

Cash flow and returns

How OKUR’s profit turns into cash, and what its capital earns

From profit to free cash flow · Last 12 months

Returns on capital · Last 12 months

  • Benchmark 15%

    -55.2%

    Return on equity

    Below the 15% mark · Profit per dollar of shareholders’ equity

  • Benchmark 5%

    -51.6%

    Return on assets

    Below the 5% mark · Profit per dollar of everything it owns

  • Benchmark 10%

    -39.1%

    Return on capital employed

    Below the 10% mark · Operating profit per dollar of long-term capital

From the company’s SEC filings. The tick on each dial is a common rule-of-thumb level, not a target.